A clinical research associate with Precision for Medicine, Carl Bazan leverages his medical training to oversee and manage the company’s projects at the company headquarters in Bethesda, Maryland. As a researcher in the medical field, Carl Bazan works to stay abreast of developments and innovations in treatment, such as precision medicine, which continues to show promise in the treatment of cancer and other serious diseases.
Traditionally, diseases have always been treated with a “one-size-fits-all” mentality. When looking at patients diagnosed with a specific condition, treatments are typically determined based on what works for the average person. Precision medicine, on the other hand, involves utilizing genetic testing to determine the unique needs of the patient and then customizing a treatment plan based on that specific condition.
Patients with cancer can especially benefit from precision medicine. After a tumor is submitted for genetic profiling, scientists can determine genetic markers and the gene mutations that might allow cells to grow out of control. Once specific markers are identified, physicians can craft a treatment plan that aims to fight cancer at a genetic level, thus improving the prognosis of the patient.
